Latest News about Disease
Recent news which mentions Disease
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
April 14, 2025
From Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
April 10, 2025
From Benzinga
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
April 08, 2025
From Benzinga
Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study
April 02, 2025
From Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
March 31, 2025
From Benzinga
Why Is Portage Biotech Stock Skyrocketing Friday?
March 28, 2025
From Benzinga
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
March 26, 2025
From Benzinga
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
March 25, 2025
From Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
March 20, 2025
Tickers
JNJ
From Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
March 19, 2025
Tickers
RGNX
From Benzinga
AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
March 17, 2025
From Benzinga
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
March 17, 2025
From Benzinga
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
March 17, 2025
From Benzinga
Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment
March 17, 2025
From Benzinga
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
March 13, 2025
From Benzinga
Cannabis Takes On Superbugs: Could This New Drug 'Change Infection Treatment Forever'?
February 05, 2025
From Benzinga
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
January 21, 2025
From Benzinga
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
January 16, 2025
From Benzinga
Twin Brothers Debut "Tuning to the Soil-ed Seed Vibrations For Our Collective Health" In 3 Formats (Paperback, Hardcover & EPUB) On 19 Dec. 2024
December 19, 2024
From PRLog
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
From Benzinga
IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
October 01, 2024
From PRLog
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
August 21, 2024
From Benzinga
From Benzinga
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
August 16, 2024
From Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
August 14, 2024
From Benzinga
Rocket Mortgage Classic Announces Inaugural 'Bow Tie Day' To Honor Founder Dan Gilbert's Son
June 26, 2023
Tickers
GOLF
From Benzinga
New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids
October 10, 2022
From Benzinga
Are HIV Patients Who Use Cannabis At Greater Risk For Heart Disease? This Cardiologist Was Granted $2.3M To Find Out
July 07, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
|
|
|